Nakasone T - Search Results

1

PDGF α receptor is a mediator for Cisplatin-induced Met expression.

Kina S, Phonaphonh T, Liang F, Kuang H, Arasaki A, Arakaki K, Nakasone T, Sunakawa H. Kina S, et al. Among authors: nakasone t. Eur J Pharmacol. 2013 Jan 15;699(1-3):227-32. doi: 10.1016/j.ejphar.2012.11.014. Epub 2012 Nov 29. Eur J Pharmacol. 2013. PMID: 23200895

2

Targeting EphA4 abrogates intrinsic resistance to chemotherapy in well-differentiated cervical cancer cell line.

Kina S, Kinjo T, Liang F, Nakasone T, Yamamoto H, Arasaki A. Kina S, et al. Among authors: nakasone t. Eur J Pharmacol. 2018 Dec 5;840:70-78. doi: 10.1016/j.ejphar.2018.09.031. Epub 2018 Sep 27. Eur J Pharmacol. 2018. PMID: 30268664

3

Regulation of chemokine production via oxidative pathway in HeLa cells.

Kina S, Nakasone T, Takemoto H, Matayoshi A, Makishi S, Sunagawa N, Liang F, Phonaphonh T, Sunakawa H. Kina S, et al. Among authors: nakasone t. Mediators Inflamm. 2009;2009:183760. doi: 10.1155/2009/183760. Epub 2010 Jan 27. Mediators Inflamm. 2009. PMID: 20150959 Free PMC article.

4

Impact of metronomic neoadjuvant chemotherapy on early tongue cancer.

Kina S, Nakasone T, Kinjo T, Maruyama T, Kawano T, Arasaki A. Kina S, et al. Among authors: nakasone t. Cancer Chemother Pharmacol. 2016 Oct;78(4):833-40. doi: 10.1007/s00280-016-3141-4. Epub 2016 Aug 30. Cancer Chemother Pharmacol. 2016. PMID: 27577260

5

Outcomes after up-front surgery and metronomic neoadjuvant chemotherapy with S-1 or UFT for early tongue squamous cell carcinoma.

Kina S, Nakasone T, Kinjo T, Nimura F, Sunagawa N, Arasaki A. Kina S, et al. Among authors: nakasone t. Clin Oral Investig. 2019 Jun;23(6):2593-2598. doi: 10.1007/s00784-018-2689-2. Epub 2018 Oct 13. Clin Oral Investig. 2019. PMID: 30317400

6

Co-expression of low-risk HPV E6/E7 and EBV LMP-1 leads to precancerous lesions by DNA damage.

Uehara K, Tanabe Y, Hirota S, Higa S, Toyoda Z, Kurima K, Kina S, Nakasone T, Arasaki A, Kinjo T. Uehara K, et al. Among authors: nakasone t. BMC Cancer. 2021 Jun 10;21(1):688. doi: 10.1186/s12885-021-08397-0. BMC Cancer. 2021. PMID: 34112111 Free PMC article.

7

miR-935 Inhibits Oral Squamous Cell Carcinoma and Targets Inositol Polyphosphate-4-phosphatase Type IA (INPP4A).

Maruyama N, Umikawa M, Matsumoto H, Maruyama T, Nishihara K, Nakasone T, Matayoshi A, Goto T, Hirano F, Arasaki A, Nakamura H, Matsuzaki G, Takaesu G. Maruyama N, et al. Among authors: nakasone t. Anticancer Res. 2020 Nov;40(11):6101-6113. doi: 10.21873/anticanres.14631. Anticancer Res. 2020. PMID: 33109548

8

Synchronous quadruple multiple primary cancers of the tongue, bilateral breasts, and kidney in a female patient with a disease-free survival time of more than 5 years: a case report.

Maruyama T, Nakasone T, Maruyama N, Matayoshi A, Arasaki A. Maruyama T, et al. Among authors: nakasone t. World J Surg Oncol. 2015 Aug 28;13:263. doi: 10.1186/s12957-015-0684-5. World J Surg Oncol. 2015. PMID: 26310238 Free PMC article.

9

Mast cell-derived VEGF enhances the passage of IgE FE-3 through the rat aortic endothelial cell monolayer.

Nakasone T, Hanashiro K, Nakamura M, Sunakawa H, Kosugi T. Nakasone T, et al. Int Arch Allergy Immunol. 2002 Sep;129(1):76-85. doi: 10.1159/000065176. Int Arch Allergy Immunol. 2002. PMID: 12373001

10

Successful tongue cancer surgery under general anesthesia in a 99-year-old patient in Okinawa, Japan: A case report and review of the literature.

Maruyama T, Nakasone T, Matayoshi A, Arasaki A. Maruyama T, et al. Among authors: nakasone t. Oncol Lett. 2016 Sep;12(3):1675-1678. doi: 10.3892/ol.2016.4864. Epub 2016 Jul 15. Oncol Lett. 2016. PMID: 27588116 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

147 results

Search Page